Clinical Trial
[Evaluation of dipyridamole efficacy as an agent for preventing acute respiratory viral diseases]
[Article in
Russian]
- PMID: 3314143
Item in Clipboard
Clinical Trial
[Evaluation of dipyridamole efficacy as an agent for preventing acute respiratory viral diseases]
[Article in
Russian]
Vopr Virusol.
1987 May-Jun.
Abstract
The epidemiological effectiveness of a low molecular interferon inducer, dipyridamole, as a means of prevention of influenza and ARD was studied in a double-blind epidemiological trial in a period of seasonal rise of ARD (Dec., 26, 1984-March 13, 1985). A statistically significant decrease of ARD incidence (1.91-fold) in the experimental group was confirmed by the results of serological studies and titrations of serum interferon in paired sera collected before the prevention and 10 days after its termination in selected subgroups from the experimental and control groups. The results indicate that the use of dipyridamole may be effective for mass prevention of influenza and ARD.
Similar articles
-
[Epidemiological trial of the prophylactic effectiveness of the interferon inducer dipyridamole with respect to influenza and acute respiratory diseases].Zh Mikrobiol Epidemiol Immunobiol. 1985 Jun;(6):26-30. Zh Mikrobiol Epidemiol Immunobiol. 1985. PMID: 3898670 Clinical Trial. Russian.
-
[Prophylaxis of respiratory infections outbreaks with dipyridamol in young servicemen].Voen Med Zh. 2004 Feb;325(2):39-43, 96. Voen Med Zh. 2004. PMID: 15101293 Clinical Trial. Russian.
-
[Dipyridamole prevention of outbreaks of respiratory infections in the homogeneous population].Klin Med (Mosk). 2004;82(11):45-9. Klin Med (Mosk). 2004. PMID: 15656399 Clinical Trial. Russian.
-
[Kagocel in the therapy of influenza and acute respiratory viral infections: Data analysis and systematization from the results of preclinical and clinical trials].Ter Arkh. 2017;89(8):113-119. doi: 10.17116/terarkh2017898113-119. Ter Arkh. 2017. PMID: 28914861 Review. Russian.
-
The present and future of specific prophylaxis of influenza and other acute viral respiratory diseases.Am Rev Respir Dis. 1974 Nov;110(5):537-41. doi: 10.1164/arrd.1974.110.5.537. Am Rev Respir Dis. 1974. PMID: 4611289 Review. No abstract available.
Cited by
-
Multi-Omics Studies towards Novel Modulators of Influenza A Virus-Host Interaction.Viruses. 2016 Sep 29;8(10):269. doi: 10.3390/v8100269. Viruses. 2016. PMID: 27690086 Free PMC article. Review.
-
Potential therapeutic effects of dipyridamole in the severely ill patients with COVID-19.Acta Pharm Sin B. 2020 Jul;10(7):1205-1215. doi: 10.1016/j.apsb.2020.04.008. Epub 2020 Apr 20. Acta Pharm Sin B. 2020. PMID: 32318327 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical
Research Materials